Skip to main content

Journal of Experimental & Clinical Cancer Research

2008 - 2024
Chevron right icon
Issue 1/2024
Latest issue

About this journal

Journal of Experimental and Clinical Cancer Research is ranked in the first quartile of oncology journals in Journal Citation Reports and is the official journal of the Regina Elena National Cancer Institute. Publishing high-quality multidisciplinary research on all aspects of basic, clinical and translational oncology studies, the journal is a valuable resource for oncologists and researchers alike. The open access platform provides visibility on a global scale and makes an impact in real time, with the journal providing authors with a first decision after submission within 30 days.

Journal of Experimental & Clinical Cancer Research
Volume 27/2008 - Volume 43/2024
BioMed Central
Electronic ISSN
Journal ID
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare